Another derivative of interest is the arylethynylquinoxaline GK-13, which demonstrated antiproliferative activity by inhibiting tissue transglutaminase 2 (TG2) [20], a ubiquitous calcium-dependent enzyme involved in apoptosis evasion and tumor cell drug resistance [21] (Figure 1). The gene discussed is TGM2; the disease is neoplasm.